Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Withdrawn

• Conditions: Colon/Rectal Cancer Rectal Cancer; Colon/Rectal Cancer Anal Cancer; Gastrointenstinal Stromal Tumor (GIST); Gynecologic Cancers Cervical Cancer; Pancreatic Cancer; Gynecologic Cancers; Hepatobiliary Cancers; Gastrointestinal Neoplasms; Gastric (Stomach) Cancer; Gastro-Esophageal(GE) Junction Cancer

• Registration Number: NCT01031056
• Lead Sponsor: Stanford University

Brief Summary

We have an active research program in gastrointestinal cancers including clinical trials, epidemiologic, and translational studies. We would like to establish a biospecimen bank linked to useful clinical information in order to learn more about diagnostic, predictive and prognostic markers for gastrointestinal cancers.

PRIMARY OBJECTIVES:

1. To collect and store tumor and normal tissue (previously collected paraffin embedded or frozen specimen) and blood in patients with gastrointestinal (GI) cancers.

SECONDARY OBJECTIVES:

1. Collect detailed clinical information via a patient questionnaire that includes demographic, socioeconomic, lifestyle, family, past medical, medication and cancer histories

2. Collect details about the tumor specimen extracted from patient charts.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2009-12-10
• Study First Submitted QC: 2009-12-11
• Study First Posted: 2009-12-14
• Study Start: 2010-01
• Status Verified: 2012-05
• Last Update Submitted: 2012-05-24
• Last Update Posted: 2012-05-28
• Primary Completion: 2099-01
• Study Completion: 2099-01

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Patients are eligible if they have a histologically proven gastrointestinal cancer (esophageal, gastroesophageal junction, gastric, small intestine, appendix, colon, rectum, anus, liver, gallbladder, bile ducts, pancreas, neuroendocrine, and GI stromal tumor).

2. 18 years of age or older

3. Ability to understand and the willingness to sign a written informed consent document.

Read More

Exclusion Criteria

None

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
None: Biospecimen will be collected for future research.

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States